Ontology highlight
ABSTRACT: Background
Chronic Rhinosinusitis (CRS) affects approximately 1 in 10 UK adults and impacts quality of life quality of life significantly. Response to treatment may be driven by individual CRS endotypes and therefore work to delineate biomarker clusters that may separate responders from non-responders is needed. The ongoing MACRO three-arm parallel-group trial randomises adult CRS patients to endoscopic sinus surgery, macrolide therapy or placebo.Aim
This study aims to correlate CRS endotypes with clinical parameters from the ongoing MACRO trial, including olfactory function and outcomes in terms of response to treatment using core biomarkers sets.Methods
Adult CRS patients enrolled into the MACRO trial will be recruited from participating UK otorhinolaryngology dep
SUBMITTER: Gokani SA
PROVIDER: S-EPMC10395813 | biostudies-literature | 2023
REPOSITORIES: biostudies-literature